Maze Therapeutics (MAZE) Stock Chart & Stock Price History $13.40 -0.15 (-1.11%) As of 06/13/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Maze Therapeutics Stock Price Performance The Maze Therapeutics (MAZE) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 44.86%, reflecting recent market activity. As of the latest close, Maze Therapeutics traded at $13.40 with a market cap of $586.88 million and volume of 100,659 shares. Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.12%1 Month Performance+44.86%3 Month Performance+21.93% MAZE Stock Chart for Sunday, June, 15, 2025 MAZE Chart by TradingView Maze Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$13.55$13.40-1.11%$13.48$12.70100,659 shs$586.88 million06/12/2025$12.78$13.55+6.03%$13.86$12.2783,015 shs$593.45 million06/11/2025$12.87$12.78-0.70%$13.19$12.5340,815 shs$559.73 million06/10/2025$12.81$12.87+0.47%$13.30$12.5463,168 shs$563.67 million06/09/2025$12.93$12.81-0.93%$13.40$12.6143,460 shs$561.04 million06/06/2025$13.34$12.93-3.07%$13.60$12.7867,720 shs$566.30 million06/05/2025$13.87$13.34-3.82%$13.94$12.8771,231 shs$584.25 million06/04/2025$13.66$13.87+1.54%$14.40$13.0395,616 shs$598.27 million06/03/2025$12.10$13.66+12.89%$13.78$11.71175,845 shs$598.27 million06/02/2025$10.24$12.10+18.16%$12.18$10.08227,106 shs$529.94 million Get the Latest News and Ratings for MAZE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$12.17$10.24-15.86%$12.05$9.73147,262 shs$448.48 million05/29/2025$11.48$12.17+6.01%$12.25$11.1467,456 shs$533.01 million05/28/2025$11.20$11.48+2.50%$11.64$10.8080,593 shs$502.79 million05/27/2025$10.28$11.20+8.95%$11.62$10.4485,577 shs$490.53 million05/26/2025$10.28$10.28$10.40$9.7539,436 shs$450.23 million05/23/2025$10.17$10.28+1.08%$10.40$9.7539,436 shs$450.23 million05/22/2025$10.52$10.17-3.33%$10.63$9.9448,425 shs$445.42 million05/21/2025$10.11$10.52+4.06%$10.63$9.8798,075 shs$460.74 million05/20/2025$9.70$10.11+4.23%$10.33$9.4177,225 shs$442.79 million05/19/2025$9.25$9.70+4.86%$9.88$9.1688,405 shs$424.82 million05/16/2025$9.25$9.25$9.35$8.8184,952 shs$405.11 million05/15/2025$9.06$9.25+2.10%$9.33$8.25100,486 shs$405.11 million05/14/2025$9.86$9.06-8.11%$10.08$8.75105,888 shs$396.79 million Related Companies NewAmsterdam Pharma Stock Chart Amneal Pharmaceuticals Stock Chart Recursion Pharmaceuticals Stock Chart Kiniksa Pharmaceuticals Stock Chart Vericel Stock Chart Gemini Therapeutics Stock Chart Denali Therapeutics Stock Chart CG Oncology Stock Chart Harmony Biosciences Stock Chart Agios Pharmaceuticals Stock Chart Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MAZE) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maze Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maze Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MAZE Stock Free MAZE Stock Alerts